Alpha Teknova, Inc.
Alpha Teknova, Inc. (TKNO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TKNO · as of Jun 8, 2026
Key Statistics
Explore Alpha Teknova, Inc. Data
tkno stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
tkno competitorsTKNO
ACB
BIOA
CGC
CVRX
IMMPStock Performance
Full HistoryAbout Alpha Teknova, Inc.
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the …
what is alpha teknova, inc. · tkno stock overview · alpha teknova, inc. company profile · who is alpha teknova, inc. ceo · tkno NASDAQ · alpha teknova, inc. headquarters · alpha teknova, inc. business segments
About Stock Overview & Key Data
Alpha Teknova, Inc. (TKNO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jun 25, 2021. As of the latest trading session, TKNO stock price is $4.65, with a market capitalization of $249.3M. The stock has returned -21.59% over the past 12 months and +22.37% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Alpha Teknova, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Alpha Teknova, Inc. reported revenue of $40.5M and net income of -$17.3M. For detailed data — including Alpha Teknova, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alpha Teknova, Inc. (TKNO) stock price is $4.65. The stock is traded on NASDAQ under the ticker symbol TKNO. The 52-week range is $1.91 – $6.68.